Washington, U.S. | Xinhua | The U.S. Food and Drug Administration on Wednesday authorized Pfizer’s oral antiviral tablets for the treatment of mild-to-moderate COVID-19, the first pill approved for COVID-19 treatment in the country. The pill, called Paxlovid, is authorized for use in adults and pediatric patients 12 years of age …
Read More »Lopinavir, ritonavir combination has no effect on treating COVID-19
Kaampala, Uganda | THE INDEPENDENT | The HIV drug Lopinavir, given in combination with Ritonavir has been found not to have any effect in treating COVID-19 in the biggest drug trial to date. The findings of the trial which were published in the medical journal the Lancet involved 5,040 people …
Read More »Medicine shortage looms over coronavirus-hit Europe
The Hague, Netherlands | AFP | While the world waits for a coronavirus vaccine, medicines used to deal with the symptoms of the disease are increasingly in critically short supply in Europe, the worst-hit continent. From sedatives needed to intubate patients struggling to breathe to anti-malarial drugs heavily backed by US …
Read More »